Clinical Trials for Malignant Pleural Mesothelioma

Find clinical trials for malignant pleural mesothelioma. Discover research opportunities and treatment options in your area.

12 Active Trials Found

Showing 12 trials on this page

Page 1 of 1

APG-2449 in Patients With Advanced Solid Tumors

NCT ID: NCT03917043

This clinical trial is studying a new drug called APG-2449, which is designed to treat patients with advanced solid tumors, including specific types of lung cancer, esophageal cancer, ovarian cance...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chengdu, Sichuan, China, Fuzhou, Fujian, China +8 more

Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma

NCT ID: NCT06318286

This clinical trial is studying a combination of three treatments—pembrolizumab, lenvatinib, and chemotherapy—for patients with a serious type of lung cancer called malignant pleural mesothelioma. ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Nishinomiya, Hyogo, Japan

A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma

NCT ID: NCT04897022

This clinical trial is investigating a new treatment approach for people with malignant pleural mesothelioma (MPM), a type of cancer affecting the lining of the lungs. The study is looking at a com...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Basking Ridge, New Jersey, United States +6 more

Hemithoracic Arc Radiotherapy Post Pleural Decortication

NCT ID: NCT06910449

This clinical trial is studying a type of treatment called hemithoracic arc radiotherapy for patients with malignant pleural mesothelioma, a serious cancer affecting the lining of the lungs. After ...

Recruiting

Phase: NA Type: interventional Locations: Cairo, Fom Elkhalig, Egypt

Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma

NCT ID: NCT05655078

This clinical trial is studying a treatment called hemithoracic irradiation with proton therapy for patients diagnosed with malignant pleural mesothelioma (MPM), which is a type of cancer affecting...

Recruiting

Phase: NA Type: interventional Locations: Manchester, , United Kingdom, Manchester, , United Kingdom +12 more

Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

NCT ID: NCT06037941

This clinical trial is exploring a new technology called breathprinting, or electronic nose (E-Nose), to see how well it can measure how patients with malignant pleural mesothelioma (MPM) respond t...

Recruiting

Phase: NA Type: interventional Locations: New York, New York, United States, Uniondale, New York, United States +5 more

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

NCT ID: NCT05795595

The clinical trial titled "A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors" is exploring a new treatment called CTX131 for adults with certa...

Recruiting

Phase: PHASE1 Type: interventional Locations: Nashville, Tennessee, United States, Duarte, California, United States +5 more

Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma

NCT ID: NCT05765084

This clinical trial is investigating a new treatment approach for patients with a type of lung cancer called malignant pleural mesothelioma, specifically the epithelioid subtype. The study combines...

Recruiting

Phase: PHASE1 Type: interventional Locations: Edegem, Antwerp, Belgium, Ghent, , Belgium +1 more

OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition

NCT ID: NCT05425576

This clinical trial is studying a new treatment for patients with malignant pleural mesothelioma, a type of cancer that affects the lining of the lungs. The treatment being tested combines two medi...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Philadelphia, Pennsylvania, United States

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

NCT ID: NCT05278975

This clinical trial is studying a new treatment called RSO-021 for patients who have malignant pleural effusion (MPE), which is a buildup of fluid in the chest due to cancer. This trial is open to ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Glasgow, , United Kingdom, London, , United Kingdom +9 more

AMT-151 in Patients With Selected Advanced Solid Tumours

NCT ID: NCT05498597

This clinical trial is investigating a new treatment called AMT-151 for patients with certain advanced cancers, including various types of ovarian, endometrial, lung, breast, and pancreatic cancers...

Recruiting

Phase: PHASE1 Type: interventional Locations: Fuzhou, Fujian, China, Sydney, New South Wales, Australia +7 more

The IMmunotherapy Pleural 5-ALA PDT

NCT ID: NCT04400539

This clinical trial, called the IMmunotherapy Pleural 5-ALA PDT, is exploring a new treatment approach for patients with malignant pleural mesothelioma, a type of cancer that affects the lining of ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Lille, , France

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions